Coya Therapeutics to Present at Upcoming Healthcare Conferences [Yahoo! Finance]
Coya Therapeutics, Inc. (COYA)
Company Research
Source: Yahoo! Finance
developing biologics intended to enhance regulatory T cell (Treg) function, announces that CEO Howard Berman, Ph.D. will present at two upcoming healthcare conferences. On September 26, 2024, Dr. Berman will participate in a panel discussion at Munsch Hardt's 3 rd Annual Texas Health Care Transactions Conference being held at the Houstonian Hotel in Houston, Texas. The panel is titled, "Affiliations with Hospital Systems: Exploring Paths to Collaboration and M&A," and will begin at 1:15pm CT. This conference aims to connect more than 250 executives and thought leaders across today's rapidly evolving health care industry, including top executives, practitioners, consultants, private equity investors, and venture capitalists. Investors can register here for the conference and gain access to this panel discussion. On October 28, 2024, Dr. Berman and Dr. Stanley Appel, Chairman of Coya's Scientific Advisory Board, will present at the inaugural Alzheimer's Drug Discovery Foundation (AD
Show less
Read more
Impact Snapshot
Event Time:
COYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COYA alerts
High impacting Coya Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
COYA
News
- Coya Therapeutics to Participate in Fireside Chat at the Chardan 8th Annual Genetic Medicines Conference [Yahoo! Finance]Yahoo! Finance
- Coya Therapeutics to Participate in Fireside Chat at the Chardan 8th Annual Genetic Medicines ConferenceBusiness Wire
- Coya Therapeutics Announces Subcutaneously Administered COYA 302 Elicits Direct Anti-Inflammatory Effect in Brain in a Preclinical Inflammatory Mouse Model of Parkinson’s DiseaseBusiness Wire
- Coya Therapeutics, Inc. (NASDAQ: COYA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock.MarketBeat
- Coya Therapeutics to Present at Upcoming Healthcare ConferencesBusiness Wire
COYA
Analyst Actions
- 9/16/24 - HC Wainwright
COYA
Sec Filings
- 8/20/24 - Form 3
- 8/19/24 - Form 8-K
- 8/12/24 - Form 10-Q
- COYA's page on the SEC website